SpectrumDNA Azione

SpectrumDNA Debiti verso fornitori

Il Debiti Commerciali di SpectrumDNA (SPXA) al 10 ago 2026 è 74.112,00 USD.

Debiti verso fornitori

74.112,00USD

Ultimo aggiornamento:

Debiti Commerciali di SpectrumDNA ammonta a 2026 74.112,00 USD. Debiti Commerciali di SpectrumDNA ammontava a 2025 - USD. Diminuisce del % inferiore rispetto all'anno precedente.
Access this data via the Eulerpool API

SpectrumDNA Analisi delle Azioni

Cosa fa SpectrumDNA? SpectrumDNA Inc is a company specializing in the development and marketing of genetic tests and analyses. Founded in 2013, the company is based in Austin, Texas and is one of the leading companies in the field of DNA analysis. The history of SpectrumDNA goes back to its founders, Dr. Jamie Teumer and Dr. João Silveira. Both bring years of experience in genetics and molecular biology and have worked on numerous research projects. Their goal was to make genetics accessible to everyone and improve healthcare. With this drive, they founded SpectrumDNA and began to put their idea into action. SpectrumDNA's business model is based on the creation of genetic tests and analyses that allow people to know their personal risk for certain diseases or conditions and take targeted preventive measures. SpectrumDNA works closely with doctors and other healthcare experts to interpret and implement the results and recommendations of the tests. SpectrumDNA offers a variety of genetic tests and analyses targeting various areas of health and well-being. These include tests for identifying genetic risk factors for cancer, cardiovascular diseases, Alzheimer's, and Parkinson's, as well as tests for predicting behavioral traits and physical characteristics such as lactose intolerance or hair color. The company also has its own research and development department that constantly works on advancing and improving test methods and technologies. This ensures that customers at SpectrumDNA always receive the latest and most accurate information. SpectrumDNA has also specialized in developing products based on the genetic profiles of its customers. These include personalized supplements tailored to the individual needs of the customer, as well as personalized training plans based on the customer's genetic traits. Recently, SpectrumDNA has also focused its attention on the application of genetics in the beauty industry. The company has developed a procedure that allows the analysis of skin quality and aging process based on the customer's genetic profile. Based on this analysis, a personalized skincare program is created that is tailored to the individual needs and goals of the customer. Overall, SpectrumDNA is a leading company in the field of DNA analysis and specializes in personalized healthcare services. Through close collaboration with doctors and other healthcare providers, as well as constant advancement and improvement of its technologies and products, SpectrumDNA enables its customers to improve their health and well-being in a personalized and effective way. SpectrumDNA è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su SpectrumDNA azioni

Debiti Commerciali di SpectrumDNA è 74.112,00 USD nel 2026.

Su Eulerpool è possibile consultare lo sviluppo storico completo del SpectrumDNA di Debiti Commerciali dal 2006, con valori annuali, grafici e analisi dettagliate.

I debiti commerciali rappresentano il denaro dovuto ai fornitori per beni e servizi ricevuti. È un componente fondamentale della gestione del capitale di esercizio.

Il USD di Debiti Commerciali è un fattore chiave per gli investitori. I cambiamenti in questa metrica possono segnalare il miglioramento o il deterioramento dei fondamentali, impattando direttamente il prezzo delle azioni. Su Eulerpool puoi tracciare il SpectrumDNA di Debiti Commerciali storicamente e in tempo reale.

Access this data via the Eulerpool API

Bilancio — SpectrumDNA

Tutte le Metriche Finanziarie — SpectrumDNA